The World Health Organization has approved a version of a widely used cholera vaccine that could help address a surge in cases that has depleted the global vaccine stockpile and left poorer countries scrambling to contain epidemics.
WHO authorized the vaccine, made by EuBiologics, which also makes the formulation now used, last week. The new version, called Euvichol-S, is a simplified formula that uses fewer ingredients, is cheaper, and can be made more quickly than the old version.
The vaccine was shown to be help preventing the diarrheal disease in late stage research conducted in Nepal.
WHO’s approval means donor agencies like the vaccines alliance Gavi and UNICEF can now buy it for poorer countries. Leila Pakkala, director of UNICEF’s supply division, said in a statement that the agency will be able to boost supplies by more than 25%.
Hanna Cavinder announces RETURN to college basketball with Miami
In pics: Aohan Banner in Inner Mongolia builds grass grids for sand control
Farmers busy with harvesting, processing spring tea in SW China's Guizhou
Construction of Xiong'an New Area in full swing
Bengals likely to look for an offensive tackle and run
China's Hong Kong signs tax pact with Croatia
Harvest of renowned Longjing tea begins in east China
WEF chair expresses confidence in Chinese economy
Meta's newest AI model beats some peers. But its amped
Father's DIY 'excavator' toy delights daughter and wins hearts online
New York man pleads guilty to sending threats to state attorney general and Trump civil case judge
Activist and model Charli Howard reveals how her 'manipulative' ex